CD8A and influenza: Studies have confirmed that when vaccines are able to simultaneously activate CD8+ T cell responses (cellular immunity) and neutralizing antibody production (humoral immunity), they achieve optimal protection against respiratory viruses, including influenza and SARS-CoV-2 variants (131–133).